Happy Sunday!
Every other week, we send a quick digest on what’s catching our eye in private markets.
Before we get into it, here’s the chart of the day:
Non-listed BDC fundraising fell to $2 billion in Q2 2026 (an 82% drop from a year ago and the lowest quarterly total since 2020). Redemptions hit 12.4% of NAV, the highest level Stanger has ever recorded. Sponsors fulfilled 38% of requests and returned $5.9 billion (against a record $15.4 billion in requests), but net outflows still came in at roughly $3.8 billion for the quarter and $5.6 billion for H1. Aggregate NAV declined 3.1% quarter-over-quarter to approximately $122.4 billion.
In this issue:
1️⃣ Private Credit: BDC fundraising hits a five-year low. But trapped investors are not willing to take a haircut to get out (yet?)
2️⃣ Commercial Real Estate: Apollo injects $1 billion into SREIT’s affordable housing portfolio. We’ll take a closer look at the deal terms below.
3️⃣ Private Equity: who’s actually investing in continuation funds? Plus, Vanguard makes a $4 billion bet on advisor infrastructure.
Accredited Insight delivers the LP’s perspective on private credit, private equity, and CRE, drawing on hundreds of deals reviewed, and thousands of conversations. Paid subscribers gain access to our database of over 40 case studies and articles on everything from evergreen funds to due diligence (the kind of analysis that tells you what the GP pitch deck left out).
1️⃣ Private Credit
1. 26% discount was a no-go for trapped investors
Cox Capital Partners offered to purchase up to $90 million of shares in five non-traded BDCs managed by HPS, Apollo, Ares, and Blue Owl at an average 26% discount to NAV (I wrote about the Blue Owl fund here).
The result? Less than $5 million in orders. Apparently, investors want liquidity, they just don’t want to pay 26% for it. (Yet??)
Cox is now extending its tender offers to interval funds managed by Cliffwater and Variant Investments. Variant, for context, saw requests to redeem roughly 50% of its shares last quarter.
Meanwhile, on the publicly traded BDC side, the discount between NAV and share prices is starting to narrow. The S&P BDC index is up 6% QTD.
But the underlying pressure hasn’t exactly disappeared: defaults are up (you’ll find the chart here), fundraising continues to crater, while the largest public BDCs have seen their portfolios contract for three consecutive quarters, as repayments continue to outpace new originations.
2. BlackRock is shopping what’s left of TCP Capital
BlackRock is sounding out buyers for the $671 million loan portfolio remaining in TCP Capital Corp.
KBW has reportedly begun pitching the portfolio to firms including Ares, although talks are still early, Bloomberg reports. TCPC is also considering other options, including reinvesting, returning capital to shareholders, or merging with another entity.
This follows TCPC’s sale of $523 million of loans to a Pantheon-backed vehicle earlier this month. That was an interesting transaction, read the full story here:
2️⃣ Commercial Real Estate
1. SREIT’s $1 billion structured lifeline
Apollo is investing $1.02 billion in a joint venture with Starwood Real Estate Income Trust, the $22.5 billion non-traded REIT that suspended redemptions earlier this year.
The basic idea is simple:
Apollo gets 41.5% of a portfolio of ~120 affordable-housing properties,
SREIT keeps 58.5% and uses the proceeds to pay down debt.
But, as always, the interesting stuff is in the fine print (did I get you in the habit of opening SEC filings yet?)
Apollo’s investment is rated investment-grade and carries a guaranteed minimum yield that increases over time. SREIT owes those payments regardless of portfolio performance.
SREIT can buy Apollo out between years 5 and 12. If it does so in years 5–10, Apollo’s IRR is capped at 7%. The economics get increasingly expensive with a longer wait (higher minimum payments, make-whole contributions, and contingent obligations). If SREIT can’t meet those obligations, Apollo gets governance rights over the portfolio.
So the trade is pretty straightforward:
SREIT gets liquidity and time. Apollo gets a protected return.
(What do existing investors get? You tell me in comments please)
Economically, Apollo’s JV investment functions as preferred equity:
And here’s an example of a recapitalization in a one-off multifamily deal:
3️⃣ Private Equity
1. Who’s actually in continuation funds?
As continuation funds become a bigger story in PE, Preqin's latest data, as of April 2026, gives us a pretty interesting look at who's actually putting money into these vehicles:
Public pension funds (19.1%), foundations and endowments (18.8%), and private-sector pension funds (18.1%) collectively account for 56% of CV investors. Fund-of-funds managers represent another 16.6%.
You see private wealth? At just 2.5%? Of course, there's an asterisk: many fund-of-funds managers are themselves targeting wealth investors, so retail exposure is higher than this chart suggests.
👉 Here’s a fund with CVs on the books:
👉 And here’s your primer on CVs:
2. Vanguard buys Altruist for $4 billion
Last, but most certainly not least: Vanguard is buying Altruist for roughly $4 billion (WSJ). The price is more than 2x Altruist’s $1.9 billion valuation from April 2025. (Umm. Maybe not the value acquisition.)
Altruist is an AI-forward wealth technology and custody platform for independent financial advisors. It provides the plumbing behind an advisor’s practice: self-clearing brokerage, account opening, trading, portfolio management, billing, reporting, and all the other glamorous infrastructure that nobody thinks about until it breaks.
It competes directly with Schwab and Fidelity in the RIA custody space.
CEO Salim Ramji is pushing Vanguard beyond index funds and deeper into wealth-advice infrastructure.
Vanguard already has partnerships with Blackstone and Wellington to bring private-market products to the wealth channel.
This is my personal opinion, take it for what it’s worth, but I just can’t fathom how this product will set the world on fire:
But products are only half the equation. You also need the pipes (now you own the product and the distribution channel). Altruist gives Vanguard those pipes, and, importantly, lays them directly underneath the independent advisors.
Altruist will operate as a standalone business, retaining its leadership and brand.
Thanks for reading! As always, if you have any suggestions, reply to this email, leave a comment, or find me on socials (unhinged me on X, slightly more prim and proper me on LinkedIn). Have a great week!
-Leyla
P.S. New here?
Here’s where you’ll find the full archive (somewhat organized):
Interesting recent moves by Vanguard. Wonder where it will lead - a better or worse situation for your typical investor? Guess we'll see how it pans out...